Curiox Biosystems Co., Ltd (KOSDAQ:445680)
South Korea
· Delayed Price · Currency is KRW 91,700
+1,200 (1.33%)
At close: Dec 5, 2025
Curiox Biosystems Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -23,247 | -8,089 | -10,040 | -11,495 | -14,524 | -6,279 |
| Depreciation & Amortization | 2,670 | 2,578 | 1,952 | 1,598 | 1,236 | 1,120 |
| Loss (Gain) From Sale of Assets | 115.44 | 123.27 | -13.02 | 12.11 | - | - |
| Asset Writedown & Restructuring Costs | 479.78 | - | - | - | 84.1 | - |
| Stock-Based Compensation | 870.39 | 777.17 | -8.84 | 678.35 | 613.76 | 167.82 |
| Provision & Write-off of Bad Debts | 6.65 | 2.14 | 17.29 | 1.88 | 12.66 | 27.41 |
| Other Operating Activities | 10,063 | -5,163 | -334.89 | 301.64 | 7,214 | 3,307 |
| Change in Accounts Receivable | 452.99 | 2,737 | 227.68 | 1,212 | 75.22 | -2,227 |
| Change in Inventory | -1,043 | -458.81 | 195.89 | -829.5 | -1,163 | 137.56 |
| Change in Accounts Payable | -622.91 | -1,196 | -688.69 | -1,509 | 809.8 | 1,192 |
| Change in Other Net Operating Assets | 144.19 | -1,009 | 528.91 | 140.75 | 516.07 | -106.52 |
| Operating Cash Flow | -10,111 | -9,698 | -8,164 | -9,888 | -5,126 | -2,661 |
| Capital Expenditures | -255.49 | -257.88 | -211.53 | -822.86 | -261.26 | -188.39 |
| Sale of Property, Plant & Equipment | - | - | 1.79 | - | - | 58.68 |
| Sale (Purchase) of Intangibles | - | - | - | -17.9 | - | - |
| Investment in Securities | -3,000 | -4,000 | 3,125 | 5,691 | -8,007 | 2,260 |
| Other Investing Activities | 25.61 | -16.81 | -16.69 | -116.92 | -43.25 | -26.19 |
| Investing Cash Flow | -3,230 | -4,275 | 2,898 | 4,734 | -8,311 | 2,105 |
| Long-Term Debt Issued | - | 19,998 | - | - | - | 131.79 |
| Long-Term Debt Repaid | - | -397.16 | -320.22 | -236.66 | -93.69 | -34.29 |
| Net Debt Issued (Repaid) | -424.94 | 19,600 | -320.22 | -236.66 | -93.69 | 97.51 |
| Issuance of Common Stock | 788.02 | 260.9 | 17,964 | - | - | - |
| Other Financing Activities | 27.68 | -0 | -0 | - | 13,087 | - |
| Financing Cash Flow | 390.76 | 19,861 | 17,644 | -236.66 | 16,999 | 97.51 |
| Foreign Exchange Rate Adjustments | 619.03 | 390.05 | -65.54 | -15.47 | 397.85 | -185.72 |
| Net Cash Flow | -12,331 | 6,279 | 12,312 | -5,407 | 3,960 | -644.51 |
| Free Cash Flow | -10,366 | -9,956 | -8,376 | -10,711 | -5,387 | -2,849 |
| Free Cash Flow Margin | -243.44% | -217.02% | -123.39% | -148.00% | -97.54% | -64.99% |
| Free Cash Flow Per Share | -637.43 | -604.30 | -585.95 | -1509.32 | -413.36 | -218.63 |
| Cash Interest Paid | 26 | 34.68 | 25.7 | 29.23 | 9.35 | 3.2 |
| Cash Income Tax Paid | 27.4 | 50.11 | 11.81 | 16.14 | -3.84 | 8.8 |
| Levered Free Cash Flow | -17,793 | 3,490 | -3,723 | -8,886 | -4,602 | - |
| Unlevered Free Cash Flow | -16,862 | 3,929 | -3,707 | -7,150 | -3,537 | - |
| Change in Working Capital | -1,068 | 72.97 | 263.79 | -985.77 | 238.26 | -1,004 |
Source: S&P Capital IQ. Standard template. Financial Sources.